Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
China · Delayed Price · Currency is CNY 162.73
-2.97 (-1.79%)
Sep 11, 2026, 3:04 PM CST
SHE:300760 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 196,804 | 230,329 | 308,395 | 351,450 | 382,132 | 461,774 | |
Market Cap Growth | -31.83% | -25.31% | -12.25% | -8.03% | -17.25% | -10.83% |
Enterprise Value | 183,087 | 218,119 | 295,955 | 332,043 | 366,958 | 449,158 |
Last Close Price | 162.73 | 187.04 | 245.30 | 271.85 | 287.03 | 341.90 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 25.08 | 28.31 | 26.43 | 30.34 | 39.78 | 57.71 |
Forward PE | 21.52 | 24.28 | 22.32 | 26.68 | 34.86 | 48.63 |
PS Ratio | 5.74 | 6.92 | 8.40 | 10.06 | 12.58 | 18.27 |
PB Ratio | 4.34 | 5.36 | 7.57 | 10.54 | 11.94 | 17.12 |
P/TBV Ratio | 8.38 | 11.35 | 17.10 | 13.62 | 14.93 | 22.34 |
P/FCF Ratio | 21.83 | 28.41 | 29.45 | 41.97 | 37.37 | 60.79 |
P/OCF Ratio | 17.73 | 22.70 | 24.81 | 31.77 | 31.47 | 51.32 |
PEG Ratio | 3.21 | 3.12 | 1.73 | 1.28 | 1.46 | 1.63 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 5.34 | 6.55 | 8.06 | 9.51 | 12.09 | 17.77 |
EV/EBITDA Ratio | 15.95 | 20.10 | 21.58 | 25.24 | 32.80 | 47.88 |
EV/EBIT Ratio | 18.87 | 23.46 | 23.92 | 27.08 | 35.25 | 51.25 |
EV/FCF Ratio | 20.31 | 26.90 | 28.26 | 39.66 | 35.89 | 59.13 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 |
Debt / FCF Ratio | 0.04 | 0.04 | 0.03 | 0.04 | 0.02 | 0.03 |
Net Debt / Equity Ratio | -0.41 | -0.41 | -0.40 | -0.56 | -0.72 | -0.56 |
Net Debt / EBITDA Ratio | -1.63 | -1.62 | -1.19 | -1.40 | -2.05 | -1.61 |
Net Debt / FCF Ratio | -2.05 | -2.17 | -1.56 | -2.21 | -2.24 | -1.99 |
Asset Turnover | 0.57 | 0.57 | 0.70 | 0.74 | 0.72 | 0.71 |
Inventory Turnover | 2.55 | 2.77 | 3.15 | 3.19 | 2.89 | 2.50 |
Quick Ratio | 1.83 | 1.86 | 1.93 | 2.21 | 2.21 | 2.00 |
Current Ratio | 2.36 | 2.36 | 2.46 | 2.66 | 2.60 | 2.47 |
Return on Equity (ROE) | 18.51% | 20.18% | 31.69% | 35.44% | 32.60% | 31.85% |
Return on Assets (ROA) | 10.14% | 10.03% | 14.79% | 16.19% | 15.33% | 15.34% |
Return on Invested Capital (ROIC) | 31.92% | 32.60% | 56.83% | 91.30% | 87.42% | 80.74% |
Return on Capital Employed (ROCE) | 20.10% | 19.50% | 26.80% | 32.40% | 29.80% | 29.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 4.00% | 3.53% | 3.78% | 3.30% | 2.51% | 1.73% |
FCF Yield | 4.58% | 3.52% | 3.40% | 2.38% | 2.68% | 1.65% |
Dividend Yield | 2.58% | 2.34% | 2.56% | 2.13% | 1.57% | 1.02% |
Payout Ratio | 65.08% | 69.01% | 74.92% | 92.12% | 44.06% | 37.98% |
Buyback Yield / Dilution | -0.04% | -0.03% | 0.04% | -0.11% | 0.36% | 0.07% |
Total Shareholder Return | 2.54% | 2.31% | 2.60% | 2.02% | 1.93% | 1.10% |